Related Experiment Video
Updated: Aug 9, 2026

Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks
Published on: November 2, 2020
Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial
C Burrows1, J M P Holly, N J Laurence
1Department of Clinical Sciences at North Bristol, IGFs and Metabolic Endocrinology Group, University of Bristol, The Medical School, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, United Kingdom.
Abstract:
IGF-binding protein (IGFBP)-3 is generally considered to have actions that counterbalance those of IGFs and is therefore being developed as a cancer treatment. In breast tumors, however, high levels are associated with aggressive tumors and poor prognosis. Consistent with this we have demonstrated that although IGFBP-3 and a non-IGF-binding fragment (serine phosphorylation domain peptide) reduced attachment and enhanced apoptosis of Hs578T breast cancer cells cultured on collagen or laminin, it promoted their attachment and survival on fibronectin, which is abundant in the matrix of aggressive tumors. We have now examined the factors that determine whether IGFBP-3 has positive or negative actions on breast epithelial cells. IGFBP-3 also promoted survival of Hs578T cells in the presence of an antibody to the beta1-integrin subunit or when cholesterol-stabilized complexes were disrupted. These actions were blocked by IGF-I or a MAPK inhibitor. Serine phosphorylation domain peptide had similar actions on MCF-7 cells that were again reversed on fibronectin or with disruption of cholesterol-stabilized complexes and blocked by the beta1-integrin antibody. In contrast, IGFBP-3 promoted growth and survival for nonmalignant MCF-10A cells, but these effects were again reversed on fibronectin and blocked by the beta1 antibody or a MAPK inhibitor or by disruption of cholesterol-stabilized complexes. On Hs578T cells, IGFBP-3 bound to caveolin-1 and beta1-integrins, enhancing their aggregation, the recruitment of focal adhesion kinase, and the activation of MAPK. In summary, with three breast epithelial cell lines, IGFBP-3 had positive or negative effects on growth and survival dependent upon the status of cholesterol-stabilized integrin receptor complexes.
Insights
Insulin-like growth factor-binding protein 3 (IGFBP-3) exhibits dual actions on breast epithelial cells. Its effects on cell growth and survival depend on cholesterol-stabilized integrin receptor complexes and fibronectin presence.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Insulin-like growth factor-binding protein 3 (IGFBP-3) is typically viewed as counteracting IGF actions and is explored for cancer therapy.
- However, elevated IGFBP-3 levels in breast tumors correlate with aggressive disease and poor prognosis.
- This suggests context-dependent roles for IGFBP-3 in breast cancer progression.
Purpose of the Study:
- To investigate the factors determining whether IGFBP-3 exerts positive or negative effects on breast epithelial cells.
- To elucidate the mechanisms underlying IGFBP-3's differential actions in various cellular contexts.
Main Methods:
- Utilized three breast epithelial cell lines (Hs578T, MCF-7, MCF-10A) cultured on different extracellular matrix components (collagen, laminin, fibronectin).
- Assessed cell attachment, apoptosis, growth, and survival under various conditions, including treatment with IGFBP-3, a serine phosphorylation domain peptide, IGF-I, MAPK inhibitors, and beta1-integrin antibodies.
- Investigated molecular interactions of IGFBP-3 with caveolin-1, beta1-integrins, focal adhesion kinase, and MAPK signaling pathways.
Main Results:
- IGFBP-3 promoted attachment and survival of Hs578T cells on fibronectin, contrasting its effects on collagen/laminin.
- IGFBP-3's pro-survival effects on Hs578T and MCF-7 cells were linked to beta1-integrin, MAPK signaling, and cholesterol-stabilized complexes.
- IGFBP-3 promoted growth and survival in nonmalignant MCF-10A cells, but these effects were context-dependent, being reversed by fibronectin, beta1-integrin blockade, or disruption of cholesterol-stabilized complexes.
- On Hs578T cells, IGFBP-3 bound to caveolin-1 and beta1-integrins, promoting aggregation and activating MAPK signaling.
Conclusions:
- IGFBP-3 exhibits context-dependent actions on breast epithelial cells, influencing growth and survival.
- The status of cholesterol-stabilized integrin receptor complexes and the extracellular matrix component fibronectin are critical determinants of IGFBP-3's effects.
- These findings highlight the complex role of IGFBP-3 in breast cancer and suggest therapeutic strategies targeting these molecular interactions.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

